Femasys (FEMY) Competitors $1.14 0.00 (0.00%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FEMY vs. SGHT, STIM, OBIO, INFU, AVR, ZJYL, KRMD, MGRM, FONR, and NSPRShould you be buying Femasys stock or one of its competitors? The main competitors of Femasys include Sight Sciences (SGHT), Neuronetics (STIM), Orchestra BioMed (OBIO), InfuSystem (INFU), Anteris Technologies Global (AVR), Jin Medical International (ZJYL), KORU Medical Systems (KRMD), Monogram Orthopaedics (MGRM), FONAR (FONR), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry. Femasys vs. Sight Sciences Neuronetics Orchestra BioMed InfuSystem Anteris Technologies Global Jin Medical International KORU Medical Systems Monogram Orthopaedics FONAR InspireMD Femasys (NASDAQ:FEMY) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment, community ranking and earnings. Which has preferable valuation and earnings, FEMY or SGHT? Femasys has higher earnings, but lower revenue than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFemasys$1.63M19.00-$14.25M-$0.85-1.34Sight Sciences$79.87M1.55-$55.55M-$1.03-2.34 Does the MarketBeat Community prefer FEMY or SGHT? Femasys received 16 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 75.00% of users gave Femasys an outperform vote while only 29.85% of users gave Sight Sciences an outperform vote. CompanyUnderperformOutperformFemasysOutperform Votes3675.00% Underperform Votes1225.00% Sight SciencesOutperform Votes2029.85% Underperform Votes4770.15% Do insiders and institutionals hold more shares of FEMY or SGHT? 65.3% of Femasys shares are held by institutional investors. Comparatively, 55.5% of Sight Sciences shares are held by institutional investors. 12.3% of Femasys shares are held by insiders. Comparatively, 28.9% of Sight Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, FEMY or SGHT? Femasys has a beta of -2.55, suggesting that its stock price is 355% less volatile than the S&P 500. Comparatively, Sight Sciences has a beta of 2.46, suggesting that its stock price is 146% more volatile than the S&P 500. Is FEMY or SGHT more profitable? Sight Sciences has a net margin of -63.30% compared to Femasys' net margin of -1,435.77%. Sight Sciences' return on equity of -47.28% beat Femasys' return on equity.Company Net Margins Return on Equity Return on Assets Femasys-1,435.77% -141.49% -82.30% Sight Sciences -63.30%-47.28%-32.72% Do analysts recommend FEMY or SGHT? Femasys currently has a consensus price target of $11.50, indicating a potential upside of 908.77%. Sight Sciences has a consensus price target of $3.83, indicating a potential upside of 59.06%. Given Femasys' stronger consensus rating and higher possible upside, analysts plainly believe Femasys is more favorable than Sight Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Femasys 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29 Does the media favor FEMY or SGHT? In the previous week, Sight Sciences had 6 more articles in the media than Femasys. MarketBeat recorded 7 mentions for Sight Sciences and 1 mentions for Femasys. Femasys' average media sentiment score of 1.87 beat Sight Sciences' score of 0.50 indicating that Femasys is being referred to more favorably in the media. Company Overall Sentiment Femasys Very Positive Sight Sciences Neutral SummaryFemasys beats Sight Sciences on 10 of the 17 factors compared between the two stocks. Remove Ads Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FEMY vs. The Competition Export to ExcelMetricFemasysSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.95M$4.09B$5.35B$7.58BDividend YieldN/A39.53%5.11%4.33%P/E Ratio-1.4127.6221.7517.78Price / Sales19.0046.52380.5194.51Price / CashN/A51.0838.1534.64Price / Book1.345.816.433.99Net Income-$14.25M$67.09M$3.20B$247.24M7 Day Performance1.79%5.35%9.08%8.29%1 Month Performance-27.39%-3.99%-6.04%-5.37%1 Year Performance-14.93%13.12%10.66%-0.24% Femasys Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FEMYFemasys2.627 of 5 stars$1.14flat$11.50+908.8%-12.3%$30.95M$1.63M-1.4130Positive NewsGap UpSGHTSight Sciences3.7099 of 5 stars$2.21-3.9%$3.83+73.5%-58.5%$113.45M$79.87M-2.17210Gap UpSTIMNeuronetics1.7478 of 5 stars$3.55+0.6%$5.50+54.9%-11.8%$107.74M$74.89M-2.89180Short Interest ↑Gap DownOBIOOrchestra BioMed1.7829 of 5 stars$2.83+2.5%$15.00+430.0%-42.7%$107.58M$2.64M-1.764Positive NewsGap UpINFUInfuSystem1.4233 of 5 stars$5.00+1.8%$13.00+160.0%N/A$105.05M$134.86M83.35410High Trading VolumeAVRAnteris Technologies GlobalN/A$2.90-9.9%$16.50+469.0%N/A$104.47M$2.71M0.00138Positive NewsGap UpZJYLJin Medical InternationalN/A$0.64+4.1%N/A-72.0%$100.49M$23.50M0.00245Positive NewsGap UpKRMDKORU Medical Systems2.8255 of 5 stars$2.14-6.1%$4.70+119.6%+18.3%$98.35M$33.65M-8.5680Gap UpMGRMMonogram Orthopaedics2.6373 of 5 stars$2.52+0.8%$5.40+114.3%-12.2%$88.93M$364,999.00-5.3628Short Interest ↑FONRFONAR1.3195 of 5 stars$13.00-2.8%N/A-29.7%$80.64M$101.57M11.30480Short Interest ↑NSPRInspireMD2.1714 of 5 stars$2.59-1.9%$4.75+83.4%+12.1%$76.90M$7.01M-3.4550 Remove Ads Related Companies and Tools Related Companies Sight Sciences Alternatives Neuronetics Alternatives Orchestra BioMed Alternatives InfuSystem Alternatives Anteris Technologies Global Alternatives Jin Medical International Alternatives KORU Medical Systems Alternatives Monogram Orthopaedics Alternatives FONAR Alternatives InspireMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FEMY) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FEMY Stock Free FEMY Stock Alerts